Baxter to sell its kidney-care business in a $3.8 billion deal to Carlyle Group

Date:

August 13, 2024

Shares of Baxter International Inc. gained ground early Tuesday, after the healthcare-products company announced an agreement to sell its kidney-care business — to be named Vantive — to private-equity investor Carlyle Group Inc. in a deal valued at $3.8 billion.

Source link

Antonio Pierce still looking for Raiders players to build up trust — and get off blocks

Starbucks replaces its CEO, names Chipotle chief to head the company

Alexandra Williams

Alexandra Williams is a writer and editor. Angeles. She writes about politics, art, and culture for LinkDaddy News.

Baxter to sell its kidney-care business in a $3.8 billion deal to Carlyle Group

Recent posts

Walgreens Boots Alliance’s stock slides after profit miss and lowered guidance

The financial pressures facing some swing state voters: ‘We can’t afford to live’

UBS to put Credit Suisse Real Estate Fund International into liquidation

Gold logs biggest drop since July, election may be a ‘pivot point’

Oil prices steady as traders monitor demand outlook, await Fed decision

Trump’s choice of Dr. Oz to oversee Medicare and Medicaid could be ‘devastating’ for millions of Americans

Falling oil prices may help push gas below $3 a gallon for the first time since 2021

Home builders, flooring companies and pool maker stocks rally as CPI data boosts rate-cut hopes

Israeli strikes on Iran’s ‘oil island’ could send crude prices soaring

Tim Walz promises middle-class tax cuts and help for homebuyers in DNC speech

Polymarket says the whale betting heavily on Trump is a French individual

Tripadvisor unveils mixed quarter, with 1% revenue growth, and stock drops 13%

Kamala Harris pitches student-loan forgiveness to teachers union: ‘A future where no teacher has to struggle with the burden’

Echoes of U.K.’s 2022 bond crisis weigh on Treasury market ahead of U.S. election

Harris and Trump command the market’s attention — but Jerome Powell may steal the spotlight

Related articles

Trump’s choice of Dr. Oz to oversee Medicare and Medicaid could be ‘devastating’ for millions of Americans

Buy gold after its pullbacks — because it may hit $3,000 in 2025

Bitcoin sits near record high. More good news for investors: It’s now less volatile.

RFK Jr. may start a food and drug ‘culture war.’ Investors are running for cover.

Here’s what bond and gold traders are signaling about Russia’s nuclear shift

Stock market ‘finally paying more attention to tariffs’ as a potential headwind

Investors are bracing for higher-for-even-longer interest rates

RFK Jr. is not a fan of weight-loss drugs or vaccines. Stocks are tanking.

Company

Follow us